SCRIPT is now available for all NHS foundation doctors in England

19th May 2017

SCRIPT is now available for all NHS foundation doctors in England

19 May 2017

From the autumn 2017 intake, SCRIPT is freely available in all Foundation Schools in England. Trainee doctors are able to access the 47 modules of the Foundation variant, covering a range of topics related to safe prescribing and therapeutics. The SCRIPT team are in the process of liaising with all Foundation Schools to ensure they implement SCRIPT into their training programme and support them to make the most of this brilliant resource.

If you are a trainee or member of staff at a Foundation School and would like to find out more, please contact the SCRIPT team on script@contacts.bham.ac.uk

Script logo

© 2017 OCB Media Ltd
All rights reserved

In association with

More News

SCRIPT eLearning Shortlisted for Prestigious HSJ Patient Safety Award

SCRIPT eLearning is delighted to announce that it has been shortlisted in the ‘Patient Safety Education and Training’ category of the HSJ Patient Safety Awards 2026, recognising its ongoing contribution to improving safety in prescribing and medicines management. The...

Birmingham Education for Health Professional Conference 2026

The SCRIPT team was delighted to present a poster at the Birmingham Education for Health Professional Conference 2026, led by our Research Associate Divya Singh. The poster, titled "eLearning in Multidisciplinary Prescribing Education: A Longitudinal Evaluation...

New Modules Under Development

We are committed to developing and adding new modules to ensure the SCRIPT programme continues to reflect current clinical practice and meets our learners’ changing needs. We have several modules at various stages of development, including Drugs of Addiction and...

Updated module – Diabetes: Antihyperglycaemic Medicines

NICE has recently updated its guidance on ‘Type 2 diabetes in adults: management’. In a change to national guidance modified‑release metformin alongside an SGLT2 inhibitor is now recommended as first‑line treatment for adults with type 2 diabetes mellitus....